Health AI Weekly Roundup (16th June - 23rd June )

Pathway Labs (US): received FDA clearance for EchoNext, an AI tool that uses routine ECGs to flag six types of structural heart disease, and partnered with OpenEvidence for clinician access. [Link]

OpenAI (US): improved health responses in GPT-5.5 Instant, available to free ChatGPT users, and reported a 71% fall in flagged health factuality issues over two months. [Link]

Midjourney (US): announced Midjourney Medical, a new division developing “Ultrasonic CT,” a proposed full-body ultrasound scanner aiming to capture whole-body images in as little as 60 seconds without radiation or magnetic fields. [Link]

Redox (US): published a healthcare data-interoperability piece arguing that AI adoption in healthcare is increasingly limited by data readiness, not model capability. [Link]

Hallmark Health Care Solutions (US): launched an AI-enabled workforce operating system to give health systems real-time visibility into staffing supply, demand, costs and incentives across fragmented workforce systems. [Link]

MedPal AI (UK): launched Juno, an agentic AI health companion powered by Anthropic’s Claude models, designed to monitor patient data through MedPal’s Health OS and provide triage, guidance and follow-up via WhatsApp and web interfaces. [Link]

MHRA National Commission into AI Regulation (UK): found broad concern that current healthcare AI regulation is insufficient, with respondents calling for shared accountability, stronger clinical evidence requirements and better post-market surveillance. [Link]

Operationalizing WHO Ethical Principles for Healthcare AI: proposed a lifecycle-aligned governance framework for healthcare AI, mapping WHO principles such as autonomy, safety, transparency and equity to practical controls across data collection, validation, deployment and monitoring. [Link]

EU AI Act amendments (EU): the European Parliament approved changes to AI Act timelines, moving standalone high-risk AI obligations to December 2027 and product-embedded safety-component obligations to August 2028, while softening but retaining AI literacy requirements. [Link]

Towards Conversational AI for Disease Management: tested Google DeepMind’s AMIE agent against 21 primary care physicians across 100 virtual OSCE cases, finding non-inferior management reasoning and stronger guideline alignment. [Link]

Towards autonomous medical artificial intelligence agents: introduced MIRA, an autonomous AI agent in a sandboxed EHR that completed simulated emergency care workflows and outperformed physician cohorts on diagnostic accuracy, with guideline-aligned and medication-safe decisions. [Link]

Privacy-Preserving Surgical Video Analysis with Swarm Learning: combined weakly supervised deep learning with decentralised Swarm Learning across six international centres to predict patient-level labels from laparoscopic appendectomy videos, achieving performance comparable to centralised training without moving data off-site. [Link]

Opmed.ai & Mayo Clinic (US): reported that Opmed.ai’s AI model improved cardiac surgery duration prediction at Mayo Clinic, reducing mean absolute error from 60 minutes to 34 minutes per case in controlled tests. [Link]

CareHQ & AIP NZ (New Zealand): are set to launch an AI-enabled teledermatology service intended to help dermatologists triage patients and speed access to skin assessments. [Link]

Prosper AI (US/Spain): raised $30 million in Series A funding led by Andreessen Horowitz to scale AI voice agents for scheduling, insurance verification and billing workflows. [Link]

Frontier Health (UK): raised $16 million in seed funding led by Atomico to scale JUNO, an AI tool for NHS administrative teams managing patient flow, test-result follow-up and care-pathway delays. [Link]

Ladder Health (US): raised $7 million in seed funding led by Nina Capital to expand its virtual-first, AI-enabled pediatric developmental therapy platform and health system partnerships. [Link]

June Health (Canada): raised $2.4 million in funding led by Securian Canada to expand its AI-enabled women’s health navigation and virtual care platform. [Link]

Simulations Plus (US): entered a $375 million agreement to be acquired by Altaris, with plans to take the drug-development software company private and combine it with Chemical Computing Group. [Link]

ChartSpan (US): acquired Validic, a personal health-data platform, to combine care management services with connected-device data and remote patient monitoring. [Link]